Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Default robots file version:2 User-agent: * Disallow: /calendar/action* Disallow: /events/action* Allow: /*.css Allow: /*.js Disallow: /*? Crawl-delay: |
Title | AIM Immunotech | Immunology for a Better |
Description | Immunology fora Better About Overview Management Team Board of Directors Scientific Advisory Board Partnering Science Pipeline Ampligen ® Immuno-Oncology Immune Disorders Viral |
Keywords | N/A |
WebSite | aimimmuno.com |
Host IP | 199.223.114.77 |
Location | - |
Site | Rank |
US$15,215,115
Last updated: 2023-05-09 07:47:00
aimimmuno.com has Semrush global rank of 695,644. aimimmuno.com has an estimated worth of US$ 15,215,115, based on its estimated Ads revenue. aimimmuno.com receives approximately 1,755,591 unique visitors each day. Its web server is located in -, with IP address 199.223.114.77. According to SiteAdvisor, aimimmuno.com is safe to visit. |
Purchase/Sale Value | US$15,215,115 |
Daily Ads Revenue | US$14,045 |
Monthly Ads Revenue | US$421,342 |
Yearly Ads Revenue | US$5,056,100 |
Daily Unique Visitors | 117,040 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
aimimmuno.com. | A | 599 | IP: 199.223.114.77 |
aimimmuno.com. | NS | 3600 | NS Record: ns20.domaincontrol.com. |
aimimmuno.com. | NS | 3600 | NS Record: ns19.domaincontrol.com. |
aimimmuno.com. | MX | 1800 | MX Record: 1 mx1-us1.ppe-hosted.com. |
aimimmuno.com. | MX | 1800 | MX Record: 0 mx1-us1.ppe-hosted.com. |
aimimmuno.com. | TXT | 1800 | TXT Record: google-site-verification=gLUhRDbSpKeR-lCRjs4vHOTqc02XC9b0uZCKuPPTa-U |
aimimmuno.com. | TXT | 1800 | TXT Record: ppe-34aff4f94ad6089c199f |
aimimmuno.com. | TXT | 1800 | TXT Record: v=spf1 include:spf.protection.outlook.com a:dispatch-us.ppe-hosted.com ~all |
aimimmuno.com. | TXT | 1800 | TXT Record: duo_sso_verification=E5GgxYbkfOGAEcS36LPBcYvBm8rFGNRVVQpaW930r33HV7qaPgZfZ7BNDMvmEh1z |
About Overview Management Team Board of Directors Scientific Advisory Board Partnering Science Pipeline Ampligen ® Immuno-Oncology Immune Disorders Viral Diseases Orphan Drug Designation Scientific Publications Clinical Trials Immuno-Oncology Immune Disorders Viral Diseases Investors Overview Press Releases Company Info Profile Management Team Presentations Events Stock Information SEC Filings Analyst Coverage Corporate Governance Governance Documents Board of Directors Committee Composition Stockholder Meeting Email Alerts Investor Contact Contact Us Select Page Immunology for a Better Future Learn More Our lead program, Ampligen ® , is an immuno-modulator that has shown broad spectrum activity in in-vitro and animal testing and is being evaluated in clinical studies for a range of debilitating and life-threatening conditions. Learn More We are working to develop solutions that have the potential to help patients across a number of disease areas, including oncology , immune disorders |
HTTP/1.1 406 Not Acceptable Server: nginx/1.21.3 Date: Sun, 31 Oct 2021 12:15:38 GMT Content-Type: text/html; charset=iso-8859-1 Connection: keep-alive Strict-Transport-Security: max-age=31536000 |
Domain Name: AIMIMMUNO.COM Registry Domain ID: 2241660041_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-03-22T17:34:01Z Creation Date: 2018-03-21T16:39:40Z Registry Expiry Date: 2022-03-21T16:39:40Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS19.DOMAINCONTROL.COM Name Server: NS20.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T22:10:27Z <<< |